Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients
about
The role of infections in autoimmune diseaseGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemCritical illness polyneuropathy and myopathy: clinical features, risk factors and prognosisComparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa.Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in BangladeshA link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni.Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.Chapter 2: Kill the bacteria...and also their messengers?Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis.Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseasesEvidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchangeStructural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.Characterization of unique modification of flagellar rod protein FlgG by Campylobacter jejuni lipid A phosphoethanolamine transferase, linking bacterial locomotion and antimicrobial peptide resistance.PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.Pathogenesis of Guillain-Barre syndrome.Identification and characterization of a lipopolysaccharide α,2,3-sialyltransferase from the human pathogen Helicobacter bizzozeroniiAntiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.Role of immunologic cross-reactivity in neurological diseases.EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence.Host-pathogen interactions in Campylobacter infections: the host perspective.Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotypingComparative studies of Campylobacter jejuni genomic diversity reveal the importance of core and dispensable genes in the biology of this enigmatic food-borne pathogen.The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharidesMonomeric and dimeric IgG fractions show differential reactivity against pathogen-derived antigens.Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.Antibodies as predictors of autoimmune diseases and cancer.Specific genetic features of Campylobacter jejuni strain G1 revealed by genome sequencing.Analysis of Campylobacter jejuni isolates of various sources for loci associated with Guillain-Barré Syndrome.Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.Detection of conserved N-linked glycans and phase-variable lipooligosaccharides and capsules from campylobacter cells by mass spectrometry and high resolution magic angle spinning NMR spectroscopy.
P2860
Q22242631-F924FADA-6802-4AAA-9F46-5B76226C0FD7Q22251013-202BFB0E-77A7-4896-80D9-43465E7E67BEQ28075974-D4975561-699B-4430-AD4B-6D3B06CE5325Q28268257-865EED58-8862-4A2E-A096-06D4684369F5Q33330309-843BB2F7-4438-4F94-A5CC-7DE5E20D9729Q33507527-922CDB03-A6B7-4BD2-8EAC-6A0C6D8BB2E6Q33535665-A433427A-9D88-4EA0-A470-C6DB74317329Q33546391-0ABA4F24-F020-4959-9214-F7AF0340ADFAQ33616742-CBAD7FE3-6DE4-4733-BE95-2C79BDEF5966Q33769180-CB365B39-ED28-4362-AFFB-C116ED921C8BQ34129949-67E76C98-234C-4293-A217-5A2F5BF04322Q34217957-24A37328-51EB-4DDE-AA83-F28247FA99F7Q34405976-CDABC3C7-E220-4AFE-9C6A-45CB9E9C8726Q34805017-22BC1CCD-A2F1-42CF-8362-BD1040B79F68Q35220367-288A6E2F-2C59-4076-8961-51AD579E91B9Q35549851-7441EA3F-2D91-4B54-9C1C-2D54DFCF676BQ35689505-4634AC1E-C6B8-4AF2-8885-8E41CC549303Q35728329-E81A4586-A9CC-4861-82FC-98C9F97BC08BQ35913793-8F8B3347-F096-4F0F-9DAE-8F32809A1201Q35917297-46571429-6921-4B61-9309-B2E4EF0C05F7Q35943153-EDE05D29-00FA-43B0-93AB-841020D50A9EQ36019417-A906ED06-0681-445E-A17C-056241520606Q36273702-C9AF1D39-F0C7-47B9-8198-EC1A5B7FD74BQ36558779-35E46858-443E-4EB9-B42F-E36EA9F97845Q36803887-F5083EE4-C714-4557-912E-72F4C387794FQ36845068-AFE495EB-0D0F-4D46-8609-2C1DAF38E59DQ36898458-C57C4273-A231-455F-BF02-2A313E42B3CCQ37111379-B0793806-86E0-4751-B647-FA87E37BEB11Q37207391-038686B8-C8C0-498A-9A8D-42EBEE6C5926Q37248125-5B03D4FC-976C-43D8-8731-A13BC10A0132Q37402885-980BDB1D-6417-4B55-B32F-615101BF2649Q37625790-CCD8990A-6D22-4932-A588-BAE3EB622C6BQ38344536-B3633D08-F458-4B29-898E-4028D5C3F837Q39588670-C6D08A5D-B5C8-487B-9299-68D5FE4381A2Q39656120-93476720-FADA-4AE6-94EF-309A75B61A09Q40086168-ADEBF022-C68B-4C55-BE44-414F3CA27EB3Q41422896-31AE64FF-351B-4D25-ABD5-EB1D7F81AAB8Q41976394-A954720D-BD51-447E-BEA7-B5BBFDEA84C9Q42058809-B9BC6ABD-7832-47A9-A7B6-E8EAE6E1B5A9Q44418925-921B2972-DF99-4A5A-97B9-2D3440674CA6
P2860
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Structure of Campylobacter jej ...... rré and Miller Fisher patients
@en
Structure of Campylobacter jej ...... ré and Miller Fisher patients.
@nl
type
label
Structure of Campylobacter jej ...... rré and Miller Fisher patients
@en
Structure of Campylobacter jej ...... ré and Miller Fisher patients.
@nl
prefLabel
Structure of Campylobacter jej ...... rré and Miller Fisher patients
@en
Structure of Campylobacter jej ...... ré and Miller Fisher patients.
@nl
P2093
P2860
P921
P1476
Structure of Campylobacter jej ...... rré and Miller Fisher patients
@en
P2093
A P Tio-Gillen
B C Jacobs
E R Wagner
H J Willison
M A De Klerk
N Van den Braak
P A Van Doorn
P2860
P304
P356
10.1128/IAI.70.3.1202-1208.2002
P407
P577
2002-03-01T00:00:00Z